🔗 Share this article

Treasury head Reeves has revealed she is planning "specific measures to tackle household expense pressures" in the forthcoming financial statement.

Speaking to media outlets, she noted that reducing inflation is a joint task of both the government and the central bank.

The United Kingdom's price growth is expected to be the most elevated among the G7 advanced economies this calendar year and the following year.

Potential Energy Cost Interventions

Reports indicate the government could take action to bring down energy bills, such as by reducing the present 5% rate of value-added tax applied on energy.

Another possibility is to reduce some of the policy costs presently added to household expenses.

Budgetary Constraints and Expert Expectations

The administration will receive the next report from the independent fiscal watchdog, the OBR, on the start of the week, which will reveal how much room there is for these measures.

The expectation from most experts is that Reeves will have to declare higher taxes or expenditure reductions in order to fulfill her self-imposed fiscal targets.

Earlier on the same day, analysis showed there was a twenty-two billion pound deficit for the chancellor to fill, which is at the more modest range of projections.

"There's a collective responsibility between the Bank of England and the administration to bear down further on some of the drivers of inflation," Reeves informed the BBC in the US capital, at the annual meetings of the International Monetary Fund and World Bank.

Revenue Commitments and Global Concerns

While much of the focus has been on expected tax rises, the chancellor said the latest data from the fiscal watchdog had not changed her commitment to election pledges not to increase rates on income tax, VAT or National Insurance.

She attributed an "unpredictable global environment" with rising international and commercial issues for the fiscal revenue measures, likely to be targeted on those "with the broadest shoulders."

International Economic Tensions

Referring to apprehensions about the UK's commercial links with China she said: "Our national security always take priority."

Recent announcement by Chinese authorities to strengthen export controls on rare earths and other resources that are essential for high-technology manufacturing led American leader Donald Trump to threaten an further 100% import tax on goods from China, raising the prospect of an all-out trade war between the two global powers.

The American finance chief labeled the Chinese decision "commercial pressure" and "a global supply chain control attempt."

Questioned on considering the American proposal to join its dispute with China, the Chancellor said she was "very concerned" by Chinese actions and called on the Beijing authorities "to avoid restrictions and restrict access."

She said the decision was "harmful for the global economy and generates additional headwinds."

"It is my opinion there are areas where we should address China, but there are also important prospects to export to China's economy, including banking sector and other areas of the economy. We've got to achieve that equilibrium right."

The chancellor also confirmed she was cooperating with international partners "regarding our own essential resources approach, so that we are less reliant."

Health Service Drug Pricing and Investment

Reeves also admitted that the cost the National Health Service pays for medicines could rise as a consequence of current talks with the Trump administration and its pharmaceutical firms, in exchange for reduced taxes and capital.

Some of the biggest global pharmaceutical manufacturers have said recently that they are either delaying or canceling projects in the UK, with several blaming the modest returns they are getting.

Recently, the government science advisor said the price the NHS pays for drugs would have to rise to stop firms and pharmaceutical investment departing from the UK.

Reeves told the BBC: "It has been observed due to the cost structure, that medical research, innovative medicines have not been provided in the UK in the extent that they are in other European countries."

"We want to make sure that individuals receiving treatment from the NHS are can access the finest critical treatments in the world. And so we are looking at all of that, and... looking to obtain increased funding into the UK."